Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1718 studies found for:    Multiple Sclerosis
Show Display Options
RSS Create an RSS feed from your search for:
Multiple Sclerosis
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Withdrawn Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life
Condition: Multiple Sclerosis
Intervention:
2 Not yet recruiting MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Other: Personal history of multiple sclerosis
3 Recruiting Physical Telerehabilitation in Veterans With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Device: Multiple Sclerosis Home Automated Telemanagement (MS HAT) system
4 Recruiting Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Procedure: Multiple Sclerosis Functional Composite;   Procedure: Mobile Multiple Sclerosis Functional Composite
5 Completed Applications of Nanotechnology in Multiple Sclerosis by Respiratory Samples
Condition: Multiple Sclerosis
Intervention: Other: NA-NOSE artificial olfactory system
6 Unknown  Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Other: Physical exercise training
7 Completed Auditory Function in Patients With and Without Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Procedure: Hearing in Multiple Sclerosis
8 Completed Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Behavioral: Constraint-Induced Movement Therapy
9 Completed Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: intravenous injection of mesenchymal stem cells;   Biological: injection of cell free media
10 Completed An Observational Study to Assess the Quality of Life of the Patients With Multiple Sclerosis and Their Caregivers
Condition: Multiple Sclerosis
Intervention:
11 Unknown  Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Procedure: Serum antibodies to infectious agents using the BioPlex 2200 and complementary EIA kits
12 Recruiting iConquerMS™ - A Patient-Powered Research Network for Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
13 Completed Natalizumab Treatment of Progressive Multiple Sclerosis
Conditions: Primary Progressive Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis
Intervention: Drug: Natalizumab
14 Terminated Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Device: Trap Myelin Test
15 Unknown  Role of Vitamin D in Reducing the Relapse Rate in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Dietary Supplement: Vitamin D3;   Dietary Supplement: Placebo
16 Recruiting Evaluation of Nutritional Status and Fatigue in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Procedure: Blood sampling;   Other: Gustatory sensitivity test using Taste strips;   Other: Questionnaires
17 Recruiting Prevalence of Fabry Disease in a Defined Population at Risk - Patients Formerly Diagnosed With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
18 Recruiting Phase 2 Study of Ublituximab in Patients With Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: Ublituximab;   Drug: Placebo
19 Unknown  A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Avonex and Topamax
20 Completed Observational Study for Assessment of the Effect of Fampyra on the Manual Function of Persons With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.